Determinants of plasma calretinin in patients with malignant pleural mesothelioma

[1]  P. Wimberger,et al.  Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer , 2019, Geburtshilfe und Frauenheilkunde.

[2]  T. Brüning,et al.  Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma , 2019, Lung.

[3]  Jonathan L. Robinson,et al.  A Systematic Investigation of the Malignant Functions and Diagnostic Potential of the Cancer Secretome , 2019, Cell reports.

[4]  B. Schwaller,et al.  Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway , 2018, Oncotarget.

[5]  T. Brüning,et al.  Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workers , 2018, Scientific Reports.

[6]  N. Maskell,et al.  Current treatments and trials in malignant pleural mesothelioma , 2018, The clinical respiratory journal.

[7]  T. Brüning,et al.  Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population , 2018, International journal of medical sciences.

[8]  J. Creaney,et al.  Malignant Mesothelioma Biomarkers: From Discovery to Use in Clinical Practice for Diagnosis, Monitoring, Screening, and Treatment , 2017, Chest.

[9]  T. Brüning,et al.  Calretinin as a blood-based biomarker for mesothelioma , 2017, BMC Cancer.

[10]  T. Brüning,et al.  Incidence of malignant mesothelioma in Germany 2009–2013 , 2017, Cancer Causes & Control.

[11]  Fuqiang Wen,et al.  Diagnostic Accuracy of Calretinin for Malignant Mesothelioma in Serous Effusions: a Meta-analysis , 2015, Scientific Reports.

[12]  B. Schwaller,et al.  Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy? , 2013, International journal of cancer.

[13]  T. Gerds,et al.  Low ERCC1 Expression in Malignant Pleural Mesotheliomas Treated with Cisplatin and Vinorelbine Predicts Prolonged Progression-Free Survival , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  J. Creaney,et al.  Serum Soluble Mesothelin Concentrations in Malignant Pleural Mesothelioma: Relationship to Tumor Volume, Clinical Stage and Changes in Tumor Burden , 2010, Clinical Cancer Research.

[15]  C. Comin,et al.  h-Caldesmon, Calretinin, Estrogen Receptor, and Ber-EP4: A Useful Combination of Immunohistochemical Markers for Differentiating Epithelioid Peritoneal Mesothelioma From Serous Papillary Carcinoma of the Ovary , 2007, The American journal of surgical pathology.

[16]  Alan T. Remaley,et al.  Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer , 2006, Clinical Cancer Research.

[17]  Joan G. Jones,et al.  Expression of Calretinin in Human Ovary, Testis, and Ovarian Sex Cord-Stromal Tumors , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  G. Viale,et al.  Calretinin: a novel immunocytochemical marker for mesothelioma. , 1996, The American journal of surgical pathology.

[19]  Robert Koch-Institut,et al.  Krebs in Deutschland 2015/2016 , 2019 .

[20]  A. Gown,et al.  Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. , 2018, Archives of pathology & laboratory medicine.

[21]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[22]  T. Brüning,et al.  Open Access Technical Advance Development of an Enzyme-linked Immunosorbent Assay for the Detection of Human Calretinin in Plasma and Serum of Mesothelioma Patients , 2022 .